SusBioME wins VentureLaunch accelerator - TechCentral ie techcentral.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcentral.ie Daily Mail and Mail on Sunday newspapers.
A new study provides insight into the effectiveness of IFX-dyyb in a real-world US population of RA patients, showing how the biosimilar compares to other treatments.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will.